Precision BioSciences
DTIL
152 hedge funds and large institutions have $96.6M invested in Precision BioSciences in 2022 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 17 closing their positions.
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
13% more funds holding
Funds holding: 134 → 152 (+18)
8% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 39
6% more call options, than puts
Call options by funds: $54K | Put options by funds: $51K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.02% less ownership
Funds ownership: 1.73% → 1.71% (-0.02%)
59% less capital invested
Capital invested by funds: $233M → $96.6M (-$137M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.81M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.62M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.56M |
| 4 |
HF
HRT Financial
New York
|
+$1.05M |
| 5 |
Two Sigma Investments
New York
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$7.08M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$5.64M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$4.68M |
| 4 |
SCM
Sio Capital Management
New York
|
-$1.9M |
| 5 |
Rafferty Asset Management
New York
|
-$1.19M |
DTIL Hedge Fund Activity: Q1 2022 in Review
152 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q1 2022, worth a combined $96.6M — down 59% from $233M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new DTIL positions and 17 closed out — a net gain of 19 holders — while 42 added to existing stakes and 39 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $2.81M. The largest seller was State Street, cutting an estimated $7.08M.
- 152 institutional investors held Precision BioSciences (DTIL) as of Q1 2022, up from 134 in Q4 2021.
- Funds reported $96.6M of Precision BioSciences stock for Q1 2022, down 59% quarter-over-quarter.
- 36 funds opened new Precision BioSciences positions in Q1 2022 and 17 closed out, a net change of +19 holders.
- The largest Precision BioSciences buyer in Q1 2022 was Acadian Asset Management, an estimated $2.81M added.
- The largest Precision BioSciences seller in Q1 2022 was State Street, an estimated $7.08M sold.
Based on aggregated 13F filings for Q1 2022.